189 results
Page 2 of 10
6-K
EX-99.2
wlkvqig96v6jlf
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.2
898ctvsd miwz87ywya
25 Oct 22
Current report (foreign)
12:27pm
6-K
EX-99.1
elhuht2a u708je2
25 Oct 22
Current report (foreign)
12:27pm
20-F/A
o6ql2v
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.1
ql4g2ctn
6 Sep 22
RepliCel Announces Non-brokered Private Placement
2:35pm
6-K
EX-99.1
tdqvb 4bxhq8
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.2
d0qcwx1iyv215
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.2
nohps1kfe9a6quk75
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.3
f5na7g20bnisd63jtiel
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.1
ff9txto
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.1
wuyi rbopbf
28 Jul 22
Current report (foreign)
2:52pm
6-K
EX-99
j3upg9
26 Jul 22
Independent Laboratory Test Results Confirm Value of DermaPreciseTM Injection Consistency in Clinical Simulation Testing
1:45pm
6-K
EX-99.1
a5e55
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.3
0jjdjc6l
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.4
e34lct2s
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.1
i9h lpn5ydvyjj78plug
17 Jun 22
Replicel Life Sciences Inc. Provides Default Status Update
12:35pm
6-K
EX-99.1
ts8bn srre
2 Jun 22
Replicel Life Sciences Inc. Provides Default Status Update
2:03pm
6-K
EX-99.1
kgxniuqko2e6yet8v
17 May 22
Replicel Life Sciences Inc. Provides Default Status Update
6:51pm
6-K
EX-99.1
uw6smlbz2mx0urovlu
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm